(HB1400)

AMENDMENT(S) PROPOSED BY THE SENATE

COMMERCE AND LABOR

1. Line 34, engrossed, after drug

strike

the remainder of line 34 and through protocols on line 35

insert

that is approved by the U.S. Food and Drug Administration for the treatment of a maternal mental health condition shall not be subject to prior authorization requirements unless there are clinically significant safety or efficacy concerns